These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17043508)

  • 1. Dosing of antirheumatic drugs in renal disease and dialysis.
    Swarup A; Sachdeva N; Schumacher HR
    J Clin Rheumatol; 2004 Aug; 10(4):190-204. PubMed ID: 17043508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antirheumatic drugs in pregnancy and lactation.
    Temprano KK; Bandlamudi R; Moore TL
    Semin Arthritis Rheum; 2005 Oct; 35(2):112-21. PubMed ID: 16194696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of antirheumatic drugs in kidney failure].
    Manganelli R; Manganelli S; Iannaccone S; De Simone W
    G Ital Nefrol; 2015; 32(6):. PubMed ID: 26845207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH; Whelton A
    Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with dosing guidelines in patients with chronic kidney disease.
    Long CL; Raebel MA; Price DW; Magid DJ
    Ann Pharmacother; 2004 May; 38(5):853-8. PubMed ID: 15054147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dosage and toxicity of antirheumatic drugs in renal insufficiency].
    Weiner SM; Bergner R
    Z Rheumatol; 2015 May; 74(4):300-9. PubMed ID: 25962451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative approach to drug dosing in chronic kidney disease.
    Olyaei AJ; Steffl JL
    Blood Purif; 2011; 31(1-3):138-45. PubMed ID: 21228582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of gout in the older adult.
    Fravel MA; Ernst ME
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):271-85. PubMed ID: 21849262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of newer antiepileptic drugs in patients with renal failure.
    Diaz A; Deliz B; Benbadis SR
    Expert Rev Neurother; 2012 Jan; 12(1):99-105. PubMed ID: 22149658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug dosing guidelines in patients with renal failure.
    Swan SK; Bennett WM
    West J Med; 1992 Jun; 156(6):633-8. PubMed ID: 1615656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
    Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
    Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts and new developments in the treatment of psoriatic arthritis.
    Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
    Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing.
    Busti AJ; Hooper JS; Amaya CJ; Kazi S
    Pharmacotherapy; 2005 Nov; 25(11):1566-91. PubMed ID: 16232020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nonsteroidal antiinflammatory drugs and the kidney].
    Zadrazil J
    Vnitr Lek; 2006; 52(7-8):686-90. PubMed ID: 16967609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial disease modifying antirheumatic drugs and prednisolone prescriptions for patients with rheumatoid arthritis: a 15-year study.
    Osiri M; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2000 Mar; 83(3):217-24. PubMed ID: 10808674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dosage of drugs in patients with kidney diseases].
    Kokot F
    Wiad Lek; 1996; 49(7-12):87-91. PubMed ID: 9245115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.